Drug Makers Shire and Baxalta Agree to a $31 Billion Union

January 11, 2016 1:25 PM

20 0

Drug Makers Shire and Baxalta Agree to a $31 Billion Union

After a courtship of more than six months, Shire won over the fellow drug maker Baxalta on Monday in a deal valued at about $31 billion. The combination would create a giant in the treatment of rare diseases.

Baxalta, which was spun out of Baxter International, generates a large portion of its sales from Advate, a drug for hemophilia. The company also has a portfolio of plasma therapies and treatments for immune diseases.

Also read: House Passes Health Bill to Speed Drug Approvals, Boost Biomedical Research

Read more

To category page

Loading...